Captrust Financial Advisors Bio Affinity Technologies, Inc. Transaction History
Captrust Financial Advisors
- $34.2 Billion
- Q4 2024
A detailed history of Captrust Financial Advisors transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 27,885 shares of BIAF stock, worth $13,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,885
Previous 27,885
-0.0%
Holding current value
$13,942
Previous $58,000
56.9%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BIAF
# of Institutions
17Shares Held
536KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$130,4340.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$49,7750.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$23,1520.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$8,8000.0% of portfolio
-
Two Sigma Securities, LLC New York, NY14.4KShares$7,2100.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $1.36M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...